SCI Ventures
VC Fund
Columbia, United States
SCI Ventures is a VC fund in Columbia focused on Apps and Finance. SCI deploys a significant portion of our resources to fund and assist talented minority and women entrepreneurs in emerging domestic markets. These emerging markets have been historically under served by private equity funding sources, despite their strong potential to convert untapped innovation into solid returns. We believe our investments inthese areas have given our firm a competitive advantage in a growing business sector that continues to create opportunities for investors and entrepreneurs alike. We especially seek to deploy capital to leverage potential opportunities in fragmented, changing industries.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries SCI Ventures invests in
Stages SCI Ventures invests in
Countries SCI Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Herbert P. Wilkins
|
|||
Joaquim Darrel Barros
|
|||
Tony Thomas
|
|||
Investment Focus
Industry
- Apps 1 (25%)
- Finance 1 (25%)
- Medical 1 (25%)
- Wearables 1 (25%)
- Biotechnology 1 (25%)
Stage
- Series A 2 (50%)
- Seed 1 (25%)
- Series B 1 (25%)
Country
- United States 2 (50%)
- Switzerland 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Herbert P. Wilkins
Founder & Managing Director
|
Founder & Managing Director | Total investments: 0 | Find email | |
|
Joaquim Darrel Barros
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
Tony Thomas
Managing Director
|
Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
OrangeX
|
OrangeX is a crypto trading company that offers spot, perpetual, and copy trading services. | $20M / Series B / Aug 29, 2025 | |
Axonis Therapeutics
|
Axonis translates breakthrough regeneration research to groundbreaking paralysis therapy, to transform the lives of spinal cord injury patients. | $115M / Series A / Oct 30, 2024 | |
|
OrangeX
|
OrangeX is a crypto trading company that offers spot, perpetual, and copy trading services. | $10M / Series A / Sep 16, 2023 | |
Augmental
|
Augmental Tech develops technology that integrates with the human body that enables to access information without the use of hands. The company actively developing discreet hands-free interfaces for people with both situational and severe motor impairment. They want to help others to overcome the physical and sensory limitations of the body and seethe mouth as unexplored real-estate for human-computer interaction.Augmental Tech enabling access to computers and increased autonomy for those living with paralysis of the upper extremities. They allowing interaction with a mobile device when constraints imposed by context prevent the use of hands. Augmental Tech was founded in 2019 and is based in Boston, Massachusetts, USA. | Seed / Aug 12, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does SCI Ventures invest in?
SCI Ventures invests primarily in Apps, Finance and Medical startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact SCI Ventures?
Public channels for SCI Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at SCI Ventures?
The team at SCI Ventures includes Herbert P. Wilkins (Founder & Managing Director), Joaquim Darrel Barros (Managing Director) and Tony Thomas (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
